AvantorMEX:AVTR 61 EBIT per Share is MXN-8.08 as of Mar. 2026. GuruFocus rates MEX:AVTR with a GF Score™ of 61/100 and a GF Value™ of MXN435.98. The stock has 4 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Avantor ranks worse than 85.22% on this metric.
Avantor's EBIT per Share for the
three
months ended in Mar. 2026 was MXN2.62.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-8.08.
During the past 12 months, the average EBIT per Share Growth Rate of Avantor was -22.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -21.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -10.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Avantor's EBIT per Share or its related term are showing as below:
MEX:AVTR'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -21.7 Med: 4 Max: 309.7
Current: -21.7
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Avantor was 309.70% per year. The lowest was -21.70% per year. And the median was 4.00% per year.
MEX:AVTR's 3-Year EBIT Growth Rate is ranked worse than 85.22% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs MEX:AVTR: -21.70
Avantor's EBIT for the
three
months ended in Mar. 2026 was MXN1,774 Mil.
Avantor (MEX:AVTR) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Avantor EBIT per Share Related Terms
Avantor EBIT per Share Historical Data
* Premium members only.
The historical data trend for Avantor's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-8.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (MEX:AVTR) has a EBIT per Share of MXN-8.08 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Avantor and its competitors. According to the industry distribution chart, Avantor ranks #588 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 85.2%.
Is Avantor's EBIT per Share too high?
Avantor's current EBIT per Share is MXN-8.08. Based on the distribution chart, Avantor ranks #588 out of 690 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avantor has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Avantor's EBIT per Share compare to ATR and TFX?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #588 out of 690 companies for EBIT per Share. This places Avantor in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current EBIT per Share is MXN-8.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Avantor (MEX:AVTR) has a current EBIT per Share of MXN-8.08. The stock's GF Value™ is MXN435.98, compared to a current price of MXN244.00 — trading 44% below its estimated fair value. The current EBIT per Share is MXN-8.08. Avantor's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Avantor (MEX:AVTR), the current EBIT per Share is MXN-8.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (MEX:AVTR) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of MXN244.00 is trading 44% below its estimated GF Value™ of MXN435.98.
Key valuation signals for MEX:AVTR:
EBIT per Share: MXN-8.08
GF Value™: MXN435.98 vs. price of MXN244.00 (44% below fair value)
No single metric tells the full story. See the MEX:AVTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
61GF Score
Get the complete analysis for MEX:AVTR
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AVTR has been successfully added to your 
